Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Sepsis

  Free Subscription


Articles published in Intensive Care Med

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    September 2022
  1. BHAVANI SV, Semler M, Qian ET, Verhoef PA, et al
    Development and validation of novel sepsis subphenotypes using trajectories of vital signs.
    Intensive Care Med. 2022 Sep 24. pii: 10.1007/s00134-022-06890.
    PubMed     Abstract available


  2. COUR M, Klouche K, Souweine B, Quenot JP, et al
    Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06872.
    PubMed     Abstract available


  3. RUSSELL JA, Meyer NJ, Walley KR
    Use of Mendelian randomization to better understand and treat sepsis.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06778.
    PubMed    


  4. DE WAELE JJ, Girardis M, Martin-Loeches I
    Source control in the management of sepsis and septic shock.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06852.
    PubMed    


    August 2022
  5. YOUNG PJ, Lamontagne F, Fujii T
    Vitamin C in sepsis.
    Intensive Care Med. 2022 Aug 12. pii: 10.1007/s00134-022-06822.
    PubMed    


    July 2022
  6. LUKASZEWSKI RA, Jones HE, Gersuk VH, Russell P, et al
    Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures.
    Intensive Care Med. 2022 Jul 13. pii: 10.1007/s00134-022-06769.
    PubMed     Abstract available


    June 2022
  7. BLOOS F, Held J, Kluge S, Simon P, et al
    (1 --> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
    Intensive Care Med. 2022 Jun 16. pii: 10.1007/s00134-022-06733.
    PubMed     Abstract available


  8. MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
    Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.
    Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
    PubMed    


    April 2022
  9. KORELL F, Schreck N, Muller-Tidow C, Dreger P, et al
    Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
    Intensive Care Med. 2022 Apr 16. pii: 10.1007/s00134-022-06676.
    PubMed    


  10. TRAN A, Fernando SM, Rochwerg B, Seymour CW, et al
    Characterizing systematic challenges in sample size determination for sepsis trials.
    Intensive Care Med. 2022 Apr 12. pii: 10.1007/s00134-022-06691.
    PubMed    


  11. POOLE D, D'Arrigo S
    Coupled plasma filtration and adsorption for the treatment of septic shock.
    Intensive Care Med. 2022;48:493-495.
    PubMed    


    March 2022
  12. BUIL JB, Schouten JA, Wauters J, van de Hoeven H, et al
    Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination.
    Intensive Care Med. 2022 Mar 22. pii: 10.1007/s00134-022-06651.
    PubMed    


  13. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Mar 18. pii: 10.1007/s00134-022-06668.
    PubMed    


  14. GIJSEN M, Dreesen E, Wauters J, Debaveye Y, et al
    The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
    Intensive Care Med. 2022 Mar 17. pii: 10.1007/s00134-022-06679.
    PubMed    


  15. HAGEL S, Pletz MW, Lehmann T
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
    Intensive Care Med. 2022 Mar 15. pii: 10.1007/s00134-022-06669.
    PubMed    


    February 2022
  16. YOSHIHIRO S, Taito S
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.
    Intensive Care Med. 2022 Feb 18. pii: 10.1007/s00134-022-06648.
    PubMed    


  17. ZHANG S, Li B, Yi S, He Z, et al
    Goal-directed therapy in sepsis strikes back. Author's reply.
    Intensive Care Med. 2022 Feb 14. pii: 10.1007/s00134-022-06633.
    PubMed    


  18. ANGRIMAN F, Rosella LC, Lawler PR, Ko DT, et al
    Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.
    Intensive Care Med. 2022 Feb 10. pii: 10.1007/s00134-022-06634.
    PubMed     Abstract available


  19. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Feb 1. pii: 10.1007/s00134-021-06609.
    PubMed     Abstract available


  20. BAKKER J, Kattan E, Annane D, Castro R, et al
    Current practice and evolving concepts in septic shock resuscitation.
    Intensive Care Med. 2022;48:148-163.
    PubMed     Abstract available


    January 2022
  21. CHEN HH, Lin CH, Wu CL, Chao WC, et al
    Incidence and risk factors of mental illness among the spouses of patients with sepsis: a population-based cohort study.
    Intensive Care Med. 2022 Jan 25. pii: 10.1007/s00134-022-06624.
    PubMed    


  22. YU K, Zhang S, Chen N, Chen M, et al
    Critical care ultrasound goal-directed versus early goal-directed therapy in septic shock.
    Intensive Care Med. 2022;48:121-123.
    PubMed    


    December 2021
  23. PETERS-SENGERS H, Butler JM, Uhel F, Schultz MJ, et al
    Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study.
    Intensive Care Med. 2021 Dec 13. pii: 10.1007/s00134-021-06574.
    PubMed     Abstract available


    November 2021
  24. FUJII T, Salanti G, Belletti A, Bellomo R, et al
    Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.
    Intensive Care Med. 2021 Nov 9. pii: 10.1007/s00134-021-06558.
    PubMed     Abstract available


  25. SKURZAK S, Gallo M, Lavezzo B, Iannandrea S, et al
    Goal-directed therapy in sepsis strikes back.
    Intensive Care Med. 2021 Nov 8. pii: 10.1007/s00134-021-06569.
    PubMed    


  26. LATERRE PF, Pickkers P, Marx G, Wittebole X, et al
    Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Intensive Care Med. 2021;47:1284-1294.
    PubMed     Abstract available


  27. GARBERO E, Livigni S, Ferrari F, Finazzi S, et al
    High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.
    Intensive Care Med. 2021;47:1303-1311.
    PubMed     Abstract available


  28. WENDEL GARCIA PD, Hilty MP, Held U, Kleinert EM, et al
    Cytokine adsorption in severe, refractory septic shock.
    Intensive Care Med. 2021;47:1334-1336.
    PubMed    


    October 2021
  29. STAHL K, Wendel-Garcia PD, Bode C, David S, et al
    Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities.
    Intensive Care Med. 2021 Oct 28. pii: 10.1007/s00134-021-06560.
    PubMed    


  30. SATO R, Hasegawa D, Dugar S
    Do we have sufficient evidence to support the use of inotropes in patients with sepsis?
    Intensive Care Med. 2021 Oct 26. pii: 10.1007/s00134-021-06564.
    PubMed    


  31. EVANS L, Rhodes A, Alhazzani W, Antonelli M, et al
    Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
    Intensive Care Med. 2021 Oct 2. pii: 10.1007/s00134-021-06506.
    PubMed    


    September 2021
  32. LIEBCHEN U, Scharf C, Zoller M, Weinelt F, et al
    No clinically relevant removal of meropenem by cytokine adsorber CytoSorb((R)) in critically ill patients with sepsis or septic shock.
    Intensive Care Med. 2021 Sep 14. pii: 10.1007/s00134-021-06487.
    PubMed    


  33. COHEN J, Blumenthal A, Cuellar-Partida G, Evans DM, et al
    The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock.
    Intensive Care Med. 2021;47:974-983.
    PubMed     Abstract available


    August 2021
  34. SWEENEY TE, Wong HR
    Transcriptional markers in response to hydrocortisone in sepsis in ADRENAL: a step toward precision medicine.
    Intensive Care Med. 2021 Aug 10. pii: 10.1007/s00134-021-06504.
    PubMed    


  35. KOSYAKOVSKY LB, Angriman F, Katz E, Adhikari NK, et al
    Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.
    Intensive Care Med. 2021 Aug 9. pii: 10.1007/s00134-021-06479.
    PubMed     Abstract available


    July 2021

  36. Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study.
    Intensive Care Med. 2021 Jul 27. pii: 10.1007/s00134-021-06478.
    PubMed    



  37. Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?
    Intensive Care Med. 2021;47:733-736.
    PubMed    


    May 2021
  38. LITTON E, Currie A, Raby E
    Probiotics and sepsis: separating the signal from the noise.
    Intensive Care Med. 2021 May 20. pii: 10.1007/s00134-021-06427.
    PubMed    


    March 2021
  39. PELLEGRINI JAS, Schwarz P, Parolo E, Cremonese RV, et al
    All that glitters is not gold: an unusual presentation of S. aureus sepsis during ECMO.
    Intensive Care Med. 2021 Mar 21. pii: 10.1007/s00134-021-06366.
    PubMed    


  40. DAVID S, Bode C, Putensen C, Welte T, et al
    Adjuvant therapeutic plasma exchange in septic shock.
    Intensive Care Med. 2021;47:352-354.
    PubMed    


    February 2021
  41. THOMPSON K, Venkatesh B, Hammond N, Taylor C, et al
    Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock.
    Intensive Care Med. 2021;47:246-248.
    PubMed    


    January 2021
  42. BUETTI N, Ruckly S, de Montmollin E, Reignier J, et al
    COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Intensive Care Med. 2021 Jan 27. pii: 10.1007/s00134-021-06346.
    PubMed     Abstract available


    July 2020
  43. AURIEMMA CL, Delucchi K, Liu KD, Calfee CS, et al
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1510-1511.
    PubMed    


  44. DE GROOTH HJ, Tuinman PR, Girbes ARJ
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1508-1509.
    PubMed    


    February 2020
  45. TIMSIT JF, Ruppe E, Barbier F, Tabah A, et al
    Bloodstream infections in critically ill patients: an expert statement.
    Intensive Care Med. 2020;46:266-284.
    PubMed     Abstract available


  46. RELLO J, Campogiani L, Eshwara VK
    Understanding resistance in enterococcal infections.
    Intensive Care Med. 2020;46:353-356.
    PubMed    


    January 2020
  47. ROIMI M, Neuberger A, Shrot A, Paul M, et al
    Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms.
    Intensive Care Med. 2020 Jan 7. pii: 10.1007/s00134-019-05876.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sepsis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: